Author:
Carter H. Ballentine,Ferrucci Luigi,Kettermann Anna,Landis Patricia,Wright E. James,Epstein Jonathan I.,Trock Bruce J.,Metter E. Jeffrey
Publisher
Oxford University Press (OUP)
Reference22 articles.
1. United States Department of Health and Human Services (Agency for Healthcare Research and Quality). U.S. Preventive Services Task Force, 2002. Available at: http://www.ahcpr.gov/clinic/uspstf/uspsprca.htm#summary . [Last accessed: May 31, 2005.]
2. Zhu H, Roehl KA, Antenor JA, Catalona WJ. Biopsy of men with PSA level of 2.6 to 4.0 ng/mL associated with favorable pathologic features and PSA progression rate: a preliminary analysis. Urology2005 ; 66 : 547 –51.
3. Carter HB. Prostate cancers in men with low PSA levels—must we find them? N Engl J Med2004 ; 350 : 2292 –4.
4. Welch HG, Schwartz LM, Woloshin S. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal. J Natl Cancer Inst2005 ; 97 : 1132 –7.
5. Carter HB, Pearson JD, Metter JE, Brant LJ, Chan DW, Andres R, et al. Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. JAMA1992 ; 267 : 2215 .
Cited by
263 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献